-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>/* Style Definitions */ span.
The second phase of the project' New Breath', plans to invite 110 hospitals across the country to register clinical data for about 18,000 asthma patients; through the establishment of a demonstration area for standardized management and treatment of asthma, and through mobile Internet medical technology, a Chinese asthma patient management collaboration network and database will be established.
Improve the disease control level of asthma patients in China
On this basis, it will promote basic and clinical translational research in the field of asthma in China; at the same time, it will provide data reference for relevant government departments in China to formulate health and medical insurance policies to benefit more Chinese asthma patients
Pauline Ng, Vice President of GSK and Head of China Prescription Medicine Department
Through this cooperation with Guangzhou Institute of Respiratory Health, we look forward to continuously promoting GSK and China Respiratory Medicine.
Group photo of guests at the project signing ceremony
Professor Lai Kefang introduced the background of the project: "The first phase of the project 'New Breath, Always Care' was launched in December 2017, and 58 hospitals in 10 regions have participated, including more than 20,000 asthma patients
.
The second phase of the project' New Breath', plans to invite 110 hospitals across the country to register clinical data for about 18,000 asthma patients; through the establishment of a demonstration area for standardized management and treatment of asthma, and through mobile Internet medical technology, a Chinese asthma patient management collaboration network and database will be established.
Improve the disease control level of asthma patients in China
According to a research survey published in The Lancet in 2019, the prevalence of asthma among people aged 20 and over in China was 4.
2%, with 45.
7 million adults.
10,000 patients with pulmonary function airflow limitation, and only 5.
6% of the patients received standardized inhaled glucocorticoid therapy, revealing the severe situation of insufficient standardized diagnosis and treatment and management of asthma in China, and highlighting the urgency of comprehensive measures to improve the overall prevention and treatment of asthma in China Sex and significance
.
Director of the National Clinical Research Center for Respiratory Diseases, Academician Zhong Nanshan of the Chinese Academy of Engineering
Academician Zhong Nanshan said: "The second-phase project 'New Breath' hopes to actively promote the formulation of asthma clinical diagnosis and treatment norms by establishing a national asthma patient registration platform based on standard asthma medical records, as well as data collection and database sharing for a single asthma disease, so as to improve the diagnosis and treatment of asthma.
On this basis, it will promote basic and clinical translational research in the field of asthma in China; at the same time, it will provide data reference for relevant government departments in China to formulate health and medical insurance policies to benefit more Chinese asthma patients
Dr.
Pauline Ng, Vice President of GSK and Head of China Prescription Medicine Department
Dr.
Pauline Ng, Vice President of GSK and Head of China Prescription Medicine Department, said: "GSK has extensive experience
in the field of global respiratory diseases and real-world medical data.
Through this cooperation with Guangzhou Institute of Respiratory Health, we look forward to continuously promoting GSK and China Respiratory Medicine.
After the signing ceremony, the two parties had a heated discussion on how the project should work with relevant units at all levels to establish a standard electronic medical record for asthma and build a national online registration database system for asthma patients, in order to provide more basis for the standardized diagnosis and treatment of asthma patients in China.
